HeartSciences to Present at the LD Micro Invitational XIV Conference

Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered

Heart Test LaboratoriesApr 2 12:00

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be RecommendedSouthlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a

Heart Test LaboratoriesMar 26 12:00

Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 Loss per Share (Vs US$0.16 Loss in 3Q 2023)

Yahoo FinanceMar 16 21:44

Heart Test Laboratories Reports Q3 Results

Seeking AlphaMar 15 05:16

Heart Test Laboratories Cash And Cash Equivalents As Of Jan. 31 Were ~$7.1M

Heart Test Laboratories Cash And Cash Equivalents As Of Jan. 31 Were ~$7.1M

BenzingaMar 15 04:26

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered

Heart Test LaboratoriesMar 14 12:00